MRKR Marker Therapeutics, Inc.: institutional ownership and insider trading
36 funds reported holding $6.32M of Marker Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $98.7K, with 4 new positions and 4 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding MRKR
- Renaissance Technologies (Renaissance Technologies): $367K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $88.5K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $47.8K, 0.0% of the portfolio
Largest institutional holders of MRKR
- NEA Management Company, LLC — $2.39M
- Blue Owl Capital Holdings LP — $815K
- VANGUARD CAPITAL MANAGEMENT LLC — $626K
- VANGUARD GROUP INC — $516K
- Aisling Capital Management LP — $478K
- RENAISSANCE TECHNOLOGIES LLC — $367K
- GEODE CAPITAL MANAGEMENT, LLC — $206K
- OSAIC HOLDINGS, INC. — $166K
- VANGUARD FIDUCIARY TRUST CO — $128K
- LPL Financial LLC — $122K
Recent MRKR insider trades
- Dec 23, 2024: Elms Steve bought 11,085 shares ($35.5K)
- Dec 23, 2024: Sandell Scott D bought 554,250 shares ($1.77M)
5%+ owners
- Blue Owl Capital Holdings LP: 10.0% (Schedule 13G/A, filed May 15, 2025)
- New Enterprise Associates 16, L.P.: 9.9% (Schedule 13D/A, filed Nov 17, 2025)
- Alyeska Investment Group, L.P.: 9.9% (Schedule 13G/A, filed Nov 14, 2025)